Literature DB >> 6264115

Phosphorylation of threonine in the proline-rich carboxy-terminal region of simian virus 40 large T antigen.

K H Scheidtmann, A Kaiser, A Carbone, G Walter.   

Abstract

The position of phosphothreonine in the predicted primary structure of simian virus 40 large T antigen was determined by different methods. After digestion of large T antigen with trypsin and subsequent two-dimensional peptide mapping, a single peptide containing phosphothreonine could be separated from the bulk of phosphoserine-containing peptides. Its amino acid composition was determined by differential labeling with various amino acids in vivo. The high yield of proline (4.5 mol) within the phosphothreonine peptide indicated that it was derived from the carboxy terminus of large T antigen and had in its unphosphorylated form the sequence Lys-Pro-Pro-Thr-Pro-Pro-Pro-Glu-Pro-Glu-Thr-COOH. A phosphopeptide generated by chymotrypsin could be converted into the tryptic phosphothreonine peptide, indicating that the latter was part of the chymotryptic peptide. The origin of the phosphothreonine-containing peptides was independently confirmed by using an antiserum directed against the carboxy terminus of large T antigen. This serum reacted specifically with the proline-rich, phosphothreonine-containing peptides. Further analysis by partial acid hydrolysis indicated that the internal threonine was phosphorylated. The unusual amino acid composition on both sides of the phosphothreonine and the possible function of this phosphorylation site are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264115      PMCID: PMC171126     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  DNA infectivity and the induction of host DNA synthesis with temperature-sensitive mutants of simian virus 40.

Authors:  J Y Chou; R G Martin
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

2.  Simian virus 40 functions required for the establishment and maintenance of malignant transformation.

Authors:  R G Martin; J Y Chou
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

3.  Genetic evidence for SV40 gene function in enhancement of replication of human adenovirus in simian cells.

Authors:  G Kimura
Journal:  Nature       Date:  1974-04-12       Impact factor: 49.962

4.  Polyoma virus proteins: a description of the structural proteins of the virion based on polyacrylamide gel electrophoresis and peptide analysis.

Authors:  W Gibson
Journal:  Virology       Date:  1974-12       Impact factor: 3.616

Review 5.  Phosphoproteins.

Authors:  G Taborsky
Journal:  Adv Protein Chem       Date:  1974

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Simian virus 40 deoxyribonucleic acid synthesis: the viral replicon.

Authors:  P Tegtmeyer
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

8.  DNA binding properties of simian virus 40 T-antigens synthesized in vivo and in vitro.

Authors:  C Prives; Y Beck; H Shure
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

9.  Viral DNA synthesis in cells infected by temperature-sensitive mutants of simian virus 40.

Authors:  J Y Chou; J Avila; R G Martin
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

10.  Biochemical consequences of type 2 adenovirus and Simian virus 40 double infections of African green monkey kidney cells.

Authors:  M P Friedman; M J Lyons; H S Ginsberg
Journal:  J Virol       Date:  1970-05       Impact factor: 5.103

View more
  19 in total

1.  Characterization of am404, an amber mutation in the simian virus 40 T antigen gene.

Authors:  D R Rawlins; P Collis; N Muzyczka
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

2.  Improved localization of phosphorylation sites in simian virus 40 large T antigen.

Authors:  F van Roy; L Fransen; W Fiers
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

3.  Phosphorylation and dephosphorylation alter the structure of D2 hybrid T antigen.

Authors:  E A Baumann; R Hand
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

4.  Differential phosphorylation of cytoplasmic and nuclear variants of simian virus 40 large T antigen encoded by simian virus 40-adenovirus 7 hybrid viruses.

Authors:  K H Scheidtmann; J Schickedanz; G Walter; R E Lanford; J S Butel
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  DNA-binding activity of simian virus 40 large T antigen correlates with a distinct phosphorylation state.

Authors:  K H Scheidtmann; M Hardung; B Echle; G Walter
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

6.  Biochemical characterization of phosphorylation site mutants of simian virus 40 large T antigen: evidence for interaction between amino- and carboxy-terminal domains.

Authors:  K H Scheidtmann; M Buck; J Schneider; D Kalderon; E Fanning; A E Smith
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Immunocytochemical search for JC papovavirus large T-antigen in multiple sclerosis brain tissue.

Authors:  G L Stoner; C F Ryschkewitsch; D L Walker; D Soffer; H D Webster
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

8.  Phosphorylation pattern of large T antigens in mouse cells infected by simian virus 40 wild type or deletion mutants.

Authors:  M Kress; M Resche-Rigon; J Feunteun
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

9.  Simian virus 40 large T antigen is phosphorylated at multiple sites clustered in two separate regions.

Authors:  K H Scheidtmann; B Echle; G Walter
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

10.  Identification of a nonvirion protein of Aleutian disease virus: mink with Aleutian disease have antibody to both virion and nonvirion proteins.

Authors:  M E Bloom; R E Race; J B Wolfinbarger
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.